O
ORIG3N
Provides the world with more knowledge about themselves based on their DNA also provides much needed COVID-19 capacity to nursing homes, boarding schools, clinicians, and underserved communities…
About ORIG3N
Orig3n operates in the genetic testing and wellness market, providing personalized DNA tests that offer insights into fitness, nutrition, and overall wellness. The company serves a diverse clientele, including individual consumers seeking to understand their genetic makeup and institutions requiring COVID-19 testing services. Orig3n's business model revolves around direct-to-consumer sales of DNA test kits and related wellness products, as well as B2B services for COVID-19 testing. Revenue is generated through the sale of these test kits and subscription-based access to personalized wellness plans. The company leverages a proprietary app to provide secure access to test results, enabling users to make informed decisions based on their unique genetic profiles.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Boston, United States
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 27.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Testing, Tech for Patients, Hard Tech, medical testing
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for ORIG3N is 320 monthly website visits, down 20% over the last three months. ORIG3N's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A12 investors entered at this stage
Hatteras Venture Partners
KTB Ventures
Mountain Group Partners
Syno Capital
LabCorp- KFKTB-KORUS Fund
DEFTA Partners
Spectrum Health Ventures- MPMGC Venture Partners
Haitong International Securities Group
VECTR
Alexandria Venture Investments
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about ORIG3N on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ORIG3N’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.